Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Gil-Sun Hong, Kyoung Won Kim, Jihyun An, Ju Hyun Shim, Jihun Kim, Eun Sil Yu

Clin Mol Hepatol. 2015;21(4):398-401. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.398

View: 8574 Download: 110 Web of Science: 4 Crossref: 6

Sun Bean Kim, Do Kyung Kim, Sun Jeong Byun, Ji Hye Park, Jin Young Choi, Young Nyun Park, Do Young Kim

Clin Mol Hepatol. 2015;21(4):387-392. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.387

View: 14026 Download: 154 Web of Science: 6 Crossref: 8

Won Jae Lee

Clin Mol Hepatol. 2009;15(3):379-382. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.379

View: 5006 Download: 33 Crossref: 2

Joon Koo Han , Se Hyung Kim

Clin Mol Hepatol. 2006;12(3):460-463. Published online January 1, 2000

View: 2703 Download: 28

1 |

Viewed By 5165	MAFLD: How is it different from NAFLD?
Viewed By 4913	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4876	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4608	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4581	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 134	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 119	MAFLD: How is it different from NAFLD?
Cited By 96	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search